Quick Answer
Oscar Health, Inc. reported Total Revenue of $11.70 billion for fiscal year 2025.
Oscar Health, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $11.70B +27.5% |
$9.18B +56.5% |
$5.86B +47.9% |
$3.96B +115.6% |
$1.84B +297.3% |
$462.80M -5.2% |
| Revenue (ASC 606) | $28.59M +39.0% |
$20.58M -3.6% |
$21.35M -67.1% |
$64.93M +1103.7% |
$5.39M | $0.00 |
| Net Income | -$443.15M -1842.5% |
$25.43M +109.4% |
-$270.73M +55.3% |
-$606.27M -5.9% |
-$572.61M -40.7% |
-$406.82M -55.8% |
| Diluted EPS | -$1.69 -1790.0% |
$0.10 +108.2% |
-$1.22 +57.2% |
-$2.85 +10.9% |
-$3.20 +77.4% |
-$14.16 -56.3% |
| Total Assets | $6.33B +30.7% |
$4.84B +34.4% |
$3.60B -20.4% |
$4.53B +36.3% |
$3.32B +46.2% |
$2.27B |
| Cash and Equivalents | $2.77B +81.7% |
$1.53B -18.3% |
$1.87B +20.0% |
$1.56B +41.2% |
$1.10B +33.6% |
$826.33M +145.5% |
| Long-Term Debt | $430.10M +43.6% |
$299.56M +0.3% |
$298.78M +0.3% |
$298.00M | $0.00 -100.0% |
$142.49M |
| Stockholders Equity | $977.65M -3.5% |
$1.01B +26.1% |
$803.97M -9.7% |
$890.38M -35.8% |
$1.39B +207.0% |
-$1.30B |
| Operating Income | -$396.36M -792.1% |
$57.27M +124.3% |
-$235.62M +60.1% |
-$589.87M -8.3% |
-$544.48M -35.4% |
-$402.27M -55.1% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $2.99B | +23.2% | +4.3% |
| Revenue (ASC 606) | September 30, 2025 | $8.80M | +79.6% | +35.5% |
| Net Income | September 30, 2025 | -$137.45M | -151.8% | +39.8% |
| Diluted EPS | September 30, 2025 | -$0.53 | -140.9% | +40.4% |
| Total Assets | September 30, 2025 | $5.75B | +28.2% | -10.0% |
| Cash and Equivalents | September 30, 2025 | $2.15B | +78.2% | -17.3% |
| Long-Term Debt | September 30, 2025 | $686.29M | +129.3% | +128.8% |
| Stockholders Equity | September 30, 2025 | $1.02B | -11.9% | -11.6% |
| Operating Income | September 30, 2025 | -$129.25M | -167.2% | +43.9% |
- Oscar Health, Inc. reported Total Revenue of $11.70 billion for fiscal year 2025.
- Oscar Health, Inc. showed an increase of +27.5% in Total Revenue compared to the prior fiscal year.
- Oscar Health, Inc. reported Revenue (ASC 606) of $28.59 million for fiscal year 2025.
- Oscar Health, Inc. showed an increase of +39.0% in Revenue (ASC 606) compared to the prior fiscal year.
- Oscar Health, Inc. reported Net Income of -$443.15 million for fiscal year 2025.
- Oscar Health, Inc. showed a decrease of -1842.5% in Net Income compared to the prior fiscal year.
- Oscar Health, Inc. reported Diluted EPS of $1.69 per share (loss) for fiscal year 2025.
- Oscar Health, Inc. showed a decrease of -1790.0% in Diluted EPS compared to the prior fiscal year.
- Oscar Health, Inc. reported Total Assets of $6.33 billion for fiscal year 2025.
- Oscar Health, Inc. showed an increase of +30.7% in Total Assets compared to the prior fiscal year.
- Oscar Health, Inc. reported Cash and Equivalents of $2.77 billion for fiscal year 2025.
- Oscar Health, Inc. showed an increase of +81.7% in Cash and Equivalents compared to the prior fiscal year.
- Oscar Health, Inc. reported Long-Term Debt of $430.10 million for fiscal year 2025.
- Oscar Health, Inc. showed an increase of +43.6% in Long-Term Debt compared to the prior fiscal year.
- Oscar Health, Inc. reported Stockholders Equity of $977.65 million for fiscal year 2025.
- Oscar Health, Inc. showed a decrease of -3.5% in Stockholders Equity compared to the prior fiscal year.
- Oscar Health, Inc. reported Operating Income of -$396.36 million for fiscal year 2025.
- Oscar Health, Inc. showed a decrease of -792.1% in Operating Income compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: